These findings are in agreement with recent publications (19, 28) and suggest that the higher sequence similarity of BA.2 with BA.2.12.1 and BA.4/5 in the S glycoprotein RBD as well as the NTD drives more efficient cross-neutralization as compared to breakthrough infections with the antigenically more distant BA.1 variant. The gene discussed is CFB; the disease is infection.